INS and Hypoglycemia: The hypoglycemia‐activated glucagon booster release from the GRS glucagon MN patch was validated on two groups of diabetic mice: one exhibiting hyperglycemic PGLs (untreated) and one undergoing hypoglycemic PGLs (treated with 15 h‐fasting and a subcutaneous injection of 75 μg kg−1 insulin).